Work on the first ever detailed international guideline on pediatric extrapolation is due to begin shortly, but achieving consensus on this much-debated topic will not be an easy task for the International Council for Harmonisation, which is expanding its membership with the result that more regulators are expected to join the discussion, AstraZeneca's Solange Corriol-Rohou told a conference in London last week.
The topic of pediatric extrapolation was briefly touched upon in a recently finalized ICH guideline - E11(R1), which is an addendum to the ICH's existing 17-year-old guideline on the clinical investigation of medicinal products in the pediatric population
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?